The two faces of interferon γ, part 2
In the first part, we focused on the dual role of IFNγ in the TME, now we analyze some cells that produce it instead. Numerous subpopulations of immune cells produce IFNγ in the tumor microenvironment (TME). For a clearer and less verbose discussion, we will deal with only some cell types: such as some subtypes […]
The two faces of interferon γ, part 1
Today the immunotherapy succeeds in providing benefit to cancer patients and in some cases leading to complete tumor elimination. However, there are some exceptions, in fact some patients do not respond to immunotherapy; this stimulates researchers to define more and more finely the borderline cases for the application of such treatment. In 1980 the interferon […]
